Nuravax’s Alzheimer’s vaccine gets $3m grant to enter human trials
HQ Team May 5, 2025: Nuravax Inc. and its partner, the Institute for Molecular Medicine, have received a $3 million grant from the.
Drugs
Health
Pharma